These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
170 related articles for article (PubMed ID: 897932)
41. [Follow-up study on the effects of buformin on the serum vitamin B-12 level and on the motility of the stomach and small intestine in diabetics]. Brunová E; Slabochová Z; Hrubá F; Nováková V; Bejblová O; Vondra K Vnitr Lek; 1978 Mar; 24(3):277-81. PubMed ID: 644896 [No Abstract] [Full Text] [Related]
42. Biguanides. Nattrass M; Alberti KG Diabetologia; 1978 Feb; 14(2):71-4. PubMed ID: 631459 [No Abstract] [Full Text] [Related]
43. [Alteration of blood lactic acid levels in biguanide therapy in diabetics]. Yang DP; Liang JZ; Luo ZT Sichuan Yi Xue Yuan Xue Bao; 1985 Jun; 16(2):162-5. PubMed ID: 3939266 [No Abstract] [Full Text] [Related]
44. [Lactic acidosis after administration of buformine (author's transl)]. Clavadetscher P; Bischof P; Wegmann T Dtsch Med Wochenschr; 1976 Feb; 101(7):238-41. PubMed ID: 1248407 [TBL] [Abstract][Full Text] [Related]
45. Insulin and longevity: antidiabetic biguanides as geroprotectors. Anisimov VN; Semenchenko AV; Yashin AI Biogerontology; 2003; 4(5):297-307. PubMed ID: 14618027 [TBL] [Abstract][Full Text] [Related]
46. [Lactacidosis in diabetic patients treated with biguanides]. Luft D; Müller PH Med Welt; 1977 Feb; 28(8):378-83. PubMed ID: 846374 [No Abstract] [Full Text] [Related]
52. [Effect of Buformin retard in adipose patients with impaired glucose tolerance]. Schräpler P; Schulz E; Adlung J Med Welt; 1975 Oct; 26(42):1919-21. PubMed ID: 1186481 [No Abstract] [Full Text] [Related]
53. [Serum concentration of lactate in diabetic patients treated with biguanides in relationship to renal function (author's transl)]. Sailer D; Ganawal S; Berg G Med Klin; 1979 Mar; 74(9):318-24. PubMed ID: 423858 [TBL] [Abstract][Full Text] [Related]
54. [Effect of butylbiguanide in retard form on the glucose resorption and lactate-pyruvate concentration in blood]. Schräpler P; Schulz E; Nijssen J; Adlung J Med Welt; 1977 Mar; 28(9):422-6. PubMed ID: 846382 [No Abstract] [Full Text] [Related]
55. Metabolic effects of glucocorticoid and ethanol administration in phenformin- and metformin-treated obese diabetics. Schaffalitzky de Muckadell OB; Mortensen H; Lyngsøe J Acta Med Scand; 1979; 206(4):269-73. PubMed ID: 506799 [TBL] [Abstract][Full Text] [Related]
56. [Physiological and pharmacological aspects of fibrinolysis]. Fearnley GR Clin Ter; 1971 May; 57(3):205-25. PubMed ID: 5110942 [No Abstract] [Full Text] [Related]
57. Biguanide related lactic acidosis: incidence and risk factors. Aguilar C; Reza A; García JE; Rull JA Arch Med Res; 1992; 23(1):19-24. PubMed ID: 1308787 [TBL] [Abstract][Full Text] [Related]
58. Letter: Lactic acidosis and biguanides. Harding AP N Z Med J; 1974 Jul; 80(519):31. PubMed ID: 4528627 [No Abstract] [Full Text] [Related]
59. [What is the role of the biguanides in the treatment of diabetes mellitus?]. Hazard J Sem Hop; 1978 Feb; 54(4):220-3. PubMed ID: 208172 [No Abstract] [Full Text] [Related]
60. [Effects and adverse effects of antidiabetic derivatives of biguanide]. Czyzyk A Med Welt; 1975 Oct; 26(42):1928-36. PubMed ID: 1102836 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]